Topical clascoterone 1% cream modestly improves inflammatory acne in teens aged 12 and older when applied twice daily for 12 weeks. Clascoterone, sold as Winlevi, is a first-in-class topical androgen receptor inhibitor that blocks male-hormone signals in oil glands and hair follicles. That action lowers sebum production and pro-inflammatory signals that drive red, tender breakouts. For teens, the evidence shows a real but limited benefit, local irritation as the main downside, and continued improvement with longer use.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- How does clascoterone target teen breakouts?
- How well does it work by week 12?
- Does benefit grow with longer use?
- What side effects should teens expect?
- How should teens use it correctly?
How does clascoterone target teen breakouts?
Clascoterone competes with dihydrotestosterone at androgen receptors in sebocytes and hair follicles. This reduces excess oil and cytokines linked to inflammatory lesions. The effect is local to treated skin.
Teen acne often flares when androgen activity increases oil and inflammation. By interrupting that signal, the cream addresses one root cause rather than only surface bacteria or clogged pores. It does not work like retinoids, benzoyl peroxide, or antibiotics.
How well does it work by week 12?
In pooled phase 3 trials of 1,421 patients aged 12 and older, 19.9% achieved treatment success versus 7.7% with vehicle, according to the Dove Medical Press review of Hebert and colleagues pooled phase 3 analysis. Success meant clear or almost clear skin with at least a two-point improvement. Lesion counts also fell more with active cream.
Teens aged 12-17 showed a similar pattern, with 17.2% reaching clear or almost clear skin versus 3.9% on vehicle, according to the Value in Health subgroup abstract adolescent subgroup analysis. Most teen users did not reach clear skin by week 12. Families should view it as a helper that improves odds, not a guaranteed fix.
Does benefit grow with longer use?
A 9-month open-label extension, totaling 12 months of exposure, showed facial clear or almost clear rates rising to 48.9%, according to Journal of Drugs in Dermatology results long-term extension results. Only 18.1% had treatment-emergent adverse events during extended use. That profile supports continued treatment when early response is partial.
Longer use does not mean stronger dosing. Teens should keep the same thin twice-daily layer unless a clinician advises otherwise. Slow, steady gains are more likely than a sudden clearing.
What side effects should teens expect?
The most common harms are local irritation: itching, burning, redness, and peeling. These problems may require a dose reduction or stopping treatment. Systemic effects are rare because absorbed drug is rapidly metabolized.
Under 14-day maximum-use testing, brief HPA-axis suppression appeared in 2 of 22 adolescents and 1 of 20 adults, then normalized within about 4 weeks after stopping. The finding suggests younger users may be more susceptible. Report prolonged fatigue, dizziness, stretch marks, slow healing, or worsening redness and swelling promptly.
How should teens use it correctly?
Clascoterone 1% cream received FDA approval on August 26, 2020 for acne vulgaris in patients 12 years and older. Safety and efficacy are not established below age 12. In Europe, adolescent use is limited to facial application.
Practical use is straightforward: The 2024 American Academy of Dermatology acne guidelines rate the evidence as high but give only a conditional recommendation because high cost may limit equitable access. The same guidelines support combining topicals with different mechanisms. A teen who tolerates clascoterone but sees partial clearing can ask about a complementary topical rather than abandoning treatment.
- Apply a thin uniform layer twice daily to clean, dry affected skin.
- Keep cream away from eyes, mouth, and mucous membranes.
- Ask a clinician before combining it with other potentially irritating topicals.
- Track redness, burning, peeling, and lesion changes for the first 12 weeks.
You Might Also Like
- Topical Hormonal Acne Treatments in a 2026 Review: What the Findings Mean for Teens With Inflammatory Acne
- Milk, Dairy, and Acne Evidence Revisited in 2026: What the Evidence Means for Teens With Acne
- Individualized Pediatric Acne Care Discussed at AAD 2026: Evidence and Practice Questions Still Open for Parents of Teens With Acne